MRD / Regn No. : SG001702 Date : 17/07/2026
Patient Name : Dipak Bose Age & Gender : 65 Yrs. / Male
Contact No. : 6296210326 UHID :
Ht / Wt / BMI : / 85 / BP S / BP D : 128 / 79
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (09/Sep/2003) | DYSLIPIDEMIA (09/Sep/2023) |
Salient Investigations : CREATININE: 1.21 | EGFR EGLOMERULAR FILTRATION RATE: 64.18 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 108 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.5 % | LDL LOW DENSITY LIPOPROTEIN: 47 mg/dL | MICROALBUMIN CREATININE RATIO: 220.5 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 343 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL
SQ 0-0-6 BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR
PO 1-0-1 BEFORE BREAKFAST AND DINNER
3 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG
PO 1-0-0 BEFORE BREAKFAST
4 TABLET ACARBOSE 50 MG
GLUCOBAY 50 MG
Medicine For DIABETES
PO 0-1-0 BEFORE LUNCH
TILL NEXT VISIT
5 TABLET ROSUVASTATIN 20 MG
STATEZE R 20
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
6 TABLET FINERENONE 20 MG
LYVELSA 20 MG
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 17/Jan/2027
Tests Suggested For Next Visit : SMBG,CHECK CREATININE,UACR:SPOT SAMPLE,HBA1C-HPLC METHOD,ECG (ALL LEADS)
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: